Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05783063
NA

iTBS for Increased Appetite Induced by Antipsychotics

Sponsor: Central South University

View on ClinicalTrials.gov

Summary

Antipsychotics are prone to cause metabolic side effects, including weight gain, hyperglycemia, insulin resistance, hyperlipidemia and so on, leading to a 2-3 times higher risk of death in patients with schizophrenia compared to healthy people. Conventional high-frequency rTMS have been used to treat people with obesity and showed certain effectiveness. However, studies involving schizophrenia patients and intermittent theta burst (iTBS) mode are rarely seen. The goal of this clinical trial is to evaluate the efficacy and safety of iTBS on ameliorating increased appetite induced by antipsychotics in people with schizophrenia.

Official title: Effects of Intermittent Theta Burst Stimulation (iTBS) on Increased Appetite Induced by Antipsychotics in Patients With Schizophrenia

Key Details

Gender

All

Age Range

18 Years - 40 Years

Study Type

INTERVENTIONAL

Enrollment

60

Start Date

2023-08-01

Completion Date

2026-08-01

Last Updated

2025-03-26

Healthy Volunteers

No

Conditions

Interventions

DEVICE

Active iTBS

Mag-TD

DEVICE

Sham iTBS

Mag-TD

Locations (2)

Central South University

Changsha, Hunan, China

The Second People's Hospital of Dali Bai Autonomous Prefecture

Dali, Yunnan, China